Mains Guidance Program (MGP) for UPSC CSE 2026, Cohort-1 starts 28th January 2025. Registrations Open Click Here to know more and registration.
What is the News?
The National Centre for Disease Control(NCDC) has released data obtained from the ‘Genome Sequencing of SARS-CoV-19’ Samples in India. UK Variant is the cause of the Current COVID-19 surge in Delhi.
Who conducted the study?
- Indian SARS-CoV-2 Consortium on Genomics(INSACOG) has conducted Genome Sequencing of around 15,000 samples. It is about 1% of India’s coronavirus caseload.
Key Findings from the study:
- Firstly, Variants of Concern(VoC): The relative proportion of known Variants of Concern or VoC (the U.K., South Africa, Brazil variants) is around 11% of the sequenced samples.
- VoC is a category used during the initial assessment of a newly emerged variant of a virus. Before this, an emerging variant may have been labeled a “variant of interest”.
- Secondly, The proportion of the UK. variant (B.1.1.7) in the samples sequenced from Delhi increased to 50% from 28% in the 2nd week of March.
- The UK variant has a mutation N501Y. It increases the transmission of the virus leading to increased disease severity and mortality.
- Thirdly, there was also a rise in the Indian variant (B.1.617). The Indian Variant possesses two mutations “E484K and L245R” that are associated with increased efficacy and decreasing the potency of vaccines.
- Fourthly, Vaccines Effectiveness: According to a Preliminary report by the CSIR-Centre for Cellular and Molecular Biology, Hyderabad, Covaxin and Covishield appeared to be effective against the Indian variant.
Source: The Hindu
Discover more from Free UPSC IAS Preparation Syllabus and Materials For Aspirants
Subscribe to get the latest posts sent to your email.